YBX1 and neoplasm: This self-reinforced regulation pathway is abnormally activated in glioblastoma to support tumor progression, and thus targeting YB-1 with RNA decoys dramatically reduces tumor growth, providing evidence that YB-1 is potentially a good target for the treatment of glioblastoma.